Resultado de búsqueda
Hace 3 días · Beta-blockers may interact with and alter the effects of other medicines. Some of the more common medicines that can interact with beta-blockers include: anti-arrhythmics – used to control irregular heartbeats; antihypertensives – used to lower blood pressure;
Hace 4 días · Calcium channel blockers (CCBs) are a class of medications that play a pivotal role in the management of hypertension. These drugs work by inhibiting the entry of calcium ions into the cells of the heart and blood vessel walls. Calcium is essential for muscle contraction, including the muscles in the heart and blood vessels.
21 de may. de 2024 · Abstract. Calcium Release-Activated Calcium (CRAC) channel is a highly Ca 2+ -selective store-operated channel constituted by two-component mediators (STIM and ORAI) and controls a wide range of cellular functions in various tissues. Gain-of-function (GoF) mutations of CRAC channel cause excessive Ca 2+ entry, which can lead to serious diseases ...
Hace 6 días · Calcium Channel Blockers. Nimodipine (Nimotop, Nymalize) View full drug information References. ... Algra A, van den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007 Jul 18. CD000277. [QxMD MEDLINE Link].
14 de may. de 2024 · Calcium channel blockers (CCBs) can worsen heart failure and may increase the risk of cardiovascular events; only the vasoselective CCBs have been shown not to adversely affect survival. Antiarrhythmic agents can have cardiodepressant effects and may promote arrhythmia; only amiodarone and dofetilide have been shown not to adversely affect survival.
21 de may. de 2024 · L-type calcium channels (LTCCs), the largest subfamily of voltage-gated calcium channels (VGCCs), are the main channels for Ca2+ influx during extracellular excitation. LTCCs are widely present in excitable cells, especially cardiac and cardiovascular smooth muscle cells, and participate in various Ca2+-dependent processes. LTCCs have been considered as worthy drug target for cardiovascular ...
21 de may. de 2024 · Published May 21, 2024. By 2031, the "Calcium Channel Blockers Market" is forecasted to reach USD xx.x Billion, underpinned by a notable compound annual growth rate (CAGR) of xx.x % from 2024 to ...
